George Mells - Concepedia

Author

George Mells

Also Known As

Avitabile, Emma, Barritt, Alfred S., Brijesh Srivastava, G F Mells, G Mells, G. F. Mells, G. Mells, G.F. Mells, G.F.G. Mells, George F Mells

154

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

University of Cambridge Newcastle University University of Birmingham Cambridge University Hospitals NHS Foundation Trust Queen Elizabeth Hospital Birmingham

About

George Mells is an author at University of Cambridge specializing in medicine, primary biliary cirrhosis, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.7K
2	Epidemiology	4	4	154
3	Health Sciences	2	2	340
4	Public Health	2	2	36
5	Cell Biology	1	1	57

George Mells

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study Thomas Marjot, Andrew M. Moon, Jonathan Cook, Journal of Hepatology	2020	519
Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid Marco Carbone, George Mells, Greta Pells, Gastroenterology HepatologyBiliary TractLiver PhysiologyHepatitisPathology	2012	374
Cholangiocyte organoids can repair bile ducts after transplantation in the human liver Fotios Sampaziotis, Daniele Muraro, Olivia Tysoe, Science	2021	348
The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis Marco Carbone, Stephen J. Sharp, Steve Flack, Hepatology	2015	335
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 Teresa Brevini, Mailis Maes, Gwilym J. Webb, Nature	2022	282
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis Jimmy Z. Liu, Mohamed A. Almarri, Daniel J. Gaffney, Nature Genetics HepatologyBiliary TractMedicineLiver PhysiologyBiliary Cancer	2012	271
Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study George Mells, Greta Pells, Julia L. Newton, Hepatology	2013	206
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study David Jones, Pol Boudes, Mark G. Swain, The Lancet. Gastroenterology & hepatology Molecular PharmacologySelective Ppar-δ AgonistHepatologyBiliary TractMedicine	2017	181
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score Marco Carbone, Alessandra Nardi, Steve Flack, The Lancet. Gastroenterology & hepatology HepatologyPretreatment PredictionBiliary TractGastroenterologyPrimary Sclerosing Cholangitis	2018	158
Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury Gary J. Doherty, Adam Duckworth, Susan Davies, ESMO Open	2017	121

Page 1